Ivabradine knocks down heart rate, symptoms in POTS
February 19, 2021
The heart failure drug also may be helpful in treating similar symptoms in patients with long-hauler COVID-19, researchers say.
More Americans hospitalized, readmitted for heart failure
February 16, 2021
“We should be emphasizing the things we know work to reduce heart failure hospitalization, which is, number one, prevention.”
ColCORONA: More questions than answers for colchicine in COVID-19
February 11, 2021
Millions of dollars and thousands of patients later, the phase 3 study highlights the challenges of COVID-19–related preprint studies without peer review.
Cardiac activity not uncommon after lifesaving measures stop
February 5, 2021
ECG and blood pressure monitoring identified resumption of cardiac activity in 14% of patients, all occurring in the 5 minutes after pulselessness.
ColCORONA: Colchicine reduces complications in outpatient COVID-19
January 25, 2021
The use of colchicine was reported to significantly reduce hospitalizations, the need for mechanical ventilation, and deaths.
Full-dose anticoagulation reduces need for life support in COVID-19
January 25, 2021
“We have treatments that are improving outcomes but not as many that reduce mortality, so we’re hopeful when the full dataset comes in that will be confirmed.”
Fracking sites tied to increased heart failure hospitalizations
December 10, 2020
The results were consistent and robust among more than 9,000 patients with heart failure in Pennsylvania, a state steeped in controversy over fracking.
Intravenous iron reduces HF readmissions: AFFIRM-AHF
November 14, 2020
The results are likely to change heart failure guidelines, which currently give a lukewarm recommendation for intravenous iron in the US, experts say.
HF an added risk in COVID-19, regardless of ejection fraction
November 3, 2020
A history of HF was associated with a near doubling risk of in-hospital mortality and ICU care.
NACMI: Clear benefit with PCI in STEMI COVID-19 patients
October 16, 2020
Angiography fell off but door-to-balloon times haven’t suffered, even with the pandemic, according to initial results from the North American registry.